Author | Erik Poulsen, MS

Articles

Darbepoetin Alfa: Impact on Treatment for Chemotherapy-Induced Anemia and Considerations in Special Populations

October 01, 2002

ByJohan Vansteenkiste, MD, PhD|Erik Poulsen, MS|Gregory Rossi, PhD|John Glaspy, MD, MPH

Our objective was to evaluate the effects of darbepoetin alfa (Aranesp) on hemoglobin and transfusions in anemic patients with cancer undergoing chemotherapy, and the impact of age, sex, baseline hemoglobin, chemotherapy